Nadolol for the treatment of infantile hemangioma.

CONCLUSION: Nadolol was an effective alternative to propranolol in three pediatric patients with hemangiomas. PMID: 25511837 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25511837?dopt=Abstract

Source: American Journal of Health-System Pharmacy : AJHP - December 19, 2014 Category: Drugs & Pharmacology Authors: Villalba-Moreno AM, Cotrina-Luque J, Del Vayo-Benito CA, Flores-Moreno S, Bautista-Paloma FJ Tags: Am J Health Syst Pharm Source Type: research